Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Purchases 90,325 Shares

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas bought 90,325 shares of the business’s stock in a transaction dated Friday, January 23rd. The shares were purchased at an average cost of $0.50 per share, with a total value of $45,162.50. Following the completion of the acquisition, the chief executive officer owned 8,182,120 shares in the company, valued at approximately $4,091,060. This represents a 1.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Grigorios Siokas also recently made the following trade(s):

• On Tuesday, January 20th, Grigorios Siokas purchased 353,321 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.50 per share, for a total transaction of $176,660.50.
• On Wednesday, January 14th, Grigorios Siokas acquired 493,495 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.45 per share, with a total value of $222,072.75.
• On Monday, January 12th, Grigorios Siokas bought 113,185 shares of Cosmos Health stock. The shares were acquired at an average price of $0.50 per share, for a total transaction of $56,592.50.
• On Thursday, January 8th, Grigorios Siokas purchased 156,190 shares of Cosmos Health stock. The stock was acquired at an average price of $0.52 per share, with a total value of $81,218.80.
• On Wednesday, January 7th, Grigorios Siokas purchased 124,880 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.52 per share, with a total value of $64,937.60.
• On Tuesday, January 6th, Grigorios Siokas purchased 133,953 shares of Cosmos Health stock. The shares were acquired at an average price of $0.54 per share, for a total transaction of $72,334.62.
• On Friday, December 19th, Grigorios Siokas acquired 88,314 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.49 per share, for a total transaction of $43,273.86.
• On Monday, December 15th, Grigorios Siokas bought 168,472 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.42 per share, with a total value of $70,758.24.
• On Friday, November 28th, Grigorios Siokas bought 76,360 shares of Cosmos Health stock. The shares were acquired at an average price of $0.64 per share, for a total transaction of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas purchased 55,732 shares of Cosmos Health stock. The stock was bought at an average cost of $0.63 per share, with a total value of $35,111.16.

Cosmos Health Stock Performance

COSM opened at $0.51 on Tuesday. The company has a quick ratio of 0.84, a current ratio of 0.99 and a debt-to-equity ratio of 0.25. The company has a market cap of $18.95 million, a price-to-earnings ratio of -0.67 and a beta of 5.37. Cosmos Health Inc. has a 52-week low of $0.28 and a 52-week high of $1.32. The firm’s fifty day simple moving average is $0.53 and its two-hundred day simple moving average is $0.74.

Cosmos Health (NASDAQ:COSM) last released its earnings results on Friday, November 14th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.16). The company had revenue of $17.11 million for the quarter, compared to analysts’ expectations of $16.40 million. Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%. Equities analysts anticipate that Cosmos Health Inc. will post -0.78 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Cosmos Health stock. Citadel Advisors LLC lifted its stake in shares of Cosmos Health Inc. (NASDAQ:COSM) by 133.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 225,507 shares of the company’s stock after purchasing an additional 128,776 shares during the period. Citadel Advisors LLC owned 0.65% of Cosmos Health worth $250,000 as of its most recent SEC filing. 12.61% of the stock is owned by institutional investors.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.